Dual impact of a nitric oxide donor, GEA 3175, in human pulmonary smooth muscle

European Journal of Pharmacology

Volumn 516, Issue 1, 2005, Pages 78-84

  Elmedal, Britt ^a   Mulvany, Michael J ^a   Simonsen, Ulf ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Human bronchiole; Human pulmonary artery; Large conductance calcium activated potassium channel; Nitric oxide donor; Soluble guanylyl cyclase

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 3 (3 CHLORO 2 METHYLPHENYL) 5 (4 METHYLBENZENESULFONYLIMINO) 1,2,3,4 OXATRIAZOLE; CALCIUM ACTIVATED POTASSIUM CHANNEL; GUANYLATE CYCLASE; IBERIOTOXIN; NITRIC OXIDE DONOR;

AIRWAY; ARTICLE; BRONCHIOLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MICROVASCULATURE; MYOGRAPHY; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SMOOTH MUSCLE; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ALBUTEROL; BRONCHI; BRONCHODILATOR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NITRIC OXIDE; NITRIC OXIDE DONORS; OXADIAZOLES; PEPTIDES; PULMONARY ARTERY; QUINOXALINES; TRIAZOLES; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 20344374948     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.04.017     Document Type: Article

References (35)

1. V.M. Bolotina, S. Najibi, J.J. Palacino, P.J. Pagano, and R.A. Cohen Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle Nature 368 1994 850 853
2. E. Cases, J.M. Vila, P. Medina, M. Aldasoro, G. Segarra, and S. Lluch Increased responsiveness of human pulmonary arteries in patients with positive bronchodilator response Br. J. Pharmacol. 119 1996 1337 1340
3. L.C. Chopra, C.H.C. Twort, and J.P.T. Ward Differences in sensitivity to the specific protein-kinase-c inhibitor Ro31-8220 between small and large bronchioles of the rat Br. J. Pharmacol. 113 1994 1237 1242
4. 2+ influx Circ. Res. 84 1999 210 219
5. +-channel blockers on beta-adrenergic- and NO-donor-mediated relaxations of human and guinea-pig airway smooth muscles Naunyn-Schmiedeberg's Arch. Pharmacol. 357 1998 77 86
6. T. Correll, S. Pedersen, B. Lissau, E. Moilanen, T.K.H. Metsäketelä, P. Vuorinen, H. Vapaatalo, E. Rydell, R. Andersson, E. Marcinkewitcz, R. Korbut, and R. Gryglewski Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems Pol. J. Pharmacol. 46 1994 553 566
7. B.H. Cuthbertson, P. Dellinger, O.J. Dyar, T.E. Evans, T. Higenbottam, R. Latimer, D. Payen, S.A. Stott, N.R. Webster, and J.D. Young UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDS Intensive Care Med. 23 1997 1212 1218
8. B. Elmedal, M.Y. Dam, M.J. Mulvany, and U. Simonsen The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats Br. J. Pharmacol. 141 2004 105 113
9. M. Feelisch, and J.S. Stamler Donors of nitric oxide M. Feelisch J. Stamler Methods in Nitric Oxide Research 1996 Wiley & Sons New York 71 119
10. C. Frostell, M.D. Fratacci, J.C. Wain, R. Jones, and W.M. Zapol Inhaled nitric-oxide-a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction Circulation 83 1991 2038 2047
11. B. Gaston, J.M. Drazen, A. Jansen, D.A. Sugarbaker, J. Loscalzo, W. Richards, and J.S. Stamler Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro J. Pharmacol. Exp. Ther. 268 1994 978 984
12. A. Haraldsson, N. Kieler-Jensen, U. Nathorst-Westfelt, C.H. Bergh, and S.E. Ricksten Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance Chest 114 1998 780 786
13. M. Hernandez, B. Elmedal, M.J. Mulvany, and U. Simonsen Mechanisms of relaxations of bovine isolated bronchioles by the nitric oxide donor, GEA 3175 Br. J. Pharmacol. 123 1998 895 905
14. P. Holm, H. Kankaanranta, T. Metsa-Ketela, and E. Moilanen Radical releasing properties of nitric oxide donors GEA 3162, SIN-1 and S-nitroso-N-acetylpenicillamine Eur. J. Pharmacol. 346 1998 97 102
15. 2+ Am. J. Physiol. 278 2000 L899 L905
16. F.R.I. Johansson, R.G. Andersson, and M. Grenegard Effects of the nitric oxide-donor, GEA 3175, on guinea-pig airways Eur. J. Pharmacol. 329 1997 175 180
17. H. Kankaanranta, E. Rydell, A.S. Petersson, P. Holm, E. Moilanen, T. Corell, G. Karup, P. Vuorinen, S.B. Pedersen, A. Wennmalm, and T. MetsaKetela Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives Br. J. Pharmacol. 117 1996 401 406
18. S.D. Lee, D.S. Kim, T.S. Shim, C.M. Lim, Y. Koh, W.S. Kim, and W.D. Kim Nitric oxide and molsidomine in the management of pulmonary hypertension in Takayasu's arteritis Chest 119 2001 302 307
19. F. Lovren, and C. Triggle Nitric oxide and sodium nitroprusside-induced relaxation of the human umbilical artery Br. J. Pharmacol. 131 2000 521 529
20. M. Miura, M.G. Belvisi, C.D. Stretton, M.H. Yacoub, and P.J. Barnes Role of potassium channels in bronchodilator responses in human airways Am. Rev. Respir. Dis. 146 1992 132 136
21. C.R. Morris, E.P. Vichinsky, J. van Warmerdam, L. Machado, D. Kepka-Lenhart, S.M. Morris, and F.A. Kuypers Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease J. Pediatr. Hematol./Oncol. 25 2003 629 634
22. M.J. Mulvany, and W. Halpern Mechanical properties of vascular smooth muscle cells in situ Nature 260 1976 617 619
23. I. Paakkari, R. Nevala, A. Peitola, and H. Vapaatalo Effect of nitric oxide donors on rat bronchial muscle in vitro Agents Actions Suppl. 45 1995 207 211
24. D.B. Palhares, C.S. Figueiredo, and A.J. Moura Endotracheal inhalatory sodium nitroprusside in severely hypoxic newborns J. Perinat. Med. 26 1998 219 224
25. W. Peng, S.V. Karwande, J.R. Hoidal, and I.S. Farrukh Potassium currents in cultured human pulmonary arterial smooth muscle cells J. Appl. Physiol. 80 1996 1187 1196
26. + channels: regulation in human pulmonary vascular smooth muscle cells Am. J. Physiol. 272 1997 C1271 C1278
27. Ca-channel activity and arterial tension in normoxic and hypoxic human pulmonary vasculature Am. J. Physiol. 275 1998 L729 L739
28. B.K.S. Sastry, C. Narasimhan, N.K. Reddy, and B.S. Raju Clinical efficacy of sildenafil in primary pulmonary hypertension-a randomized, placebo-controlled, double-blind, crossover study J. Am. Coll. Cardiol. 43 2004 1149 1153
29. M.B. Schindler, D.J. Bohn, A.C. Bryan, E. Cutz, and M. Rabinovitch Increased respiratory system resistance and bronchial smooth-muscle hypertrophy in children with acute postoperative pulmonary-hypertension Am. J. Respir. Crit. Care Med. 152 1995 1347 1352
30. + channel Exp. Physiol. 84 1999 835 846
31. K. Vaali, L. Li, B. Redemann, I. Paakkari, and H. Vapaatalo In-vitro bronchorelaxing effects of novel nitric oxide donors GEA 3268 and GEA 5145 in guinea-pigs and rats J. Pharm. Pharmacol. 48 1996 1309 1314
32. J.C. Wanstall, C.S. Kay, S.R. O'Donnell, K. Wilson, P.H. Cole, and K. Matar Evaluation of bosentan, pinacidil and nitroprusside on human pulmonary arteries: comparison with rat pulmonary arteries Fundam. Clin. Pharmacol. 11 1997 584 591
33. J.C. Wanstall, J.A. Kaye, and A. Gambino The in vitro pulmonary vascular effects of FK409 (nitric oxide donor): a study in normotensive and pulmonary hypertensive rats Br. J. Pharmacol. 121 1997 280 286
34. J.C. Wanstall, T.K. Jeffery, A. Gambino, F. Lovren, and C.R. Triggle Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion Br. J. Pharmacol. 134 2001 463 472
35. + channels Proc. Natl. Acad. Sci. U. S. A. 93 1996 10489 10494